Skip to content

Postpartum Opioid Prescribing Patterns and Patient Utilization

Postpartum Opioid Prescribing Patterns and Patient Utilization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03030742
Enrollment
494
Registered
2017-01-25
Start date
2017-06-01
Completion date
2019-12-31
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Delivery, Opioid Use, Post-operative, Postpartum

Brief summary

This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.

Detailed description

Opiate abuse is a national epidemic and has paralleled the increase in opioid prescriptions, with diversion of surplus medication playing a key contributing role. As the majority of reproductive age women in the U.S. will experience childbirth, understanding opioid prescription patterns and patient opioid utilization in the postpartum period is critical. Postpartum women will be recruited during a 9-month period to take part in pre-hospital discharge and 2-4 week postpartum surveys to prospectively assess opioid medication use with regard to quantity of opioid tablets prescribed and quantity used, storage and disposal of unused opioids and satisfaction with pain control.

Interventions

OTHERSurvey

A survey will be administered at two time points (time of hospital discharge and 2-4 weeks postpartum) to determine: * Satisfaction with pain control 2-4 weeks postpartum * Patient-reported use of opioid medication postpartum (receipt of prescription, filling of prescription, if refill was obtained, and number of opioid pills remaining at the time of follow-up) * Patient characteristics associated with high opioid use * Methods of storage and disposal of unused opioids

Sponsors

Society for Maternal-Fetal Medicine
CollaboratorUNKNOWN
Northwestern University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Women who deliver during the recruitment period * English-speaking * Opiate-naïve (as determined by admission medication reconciliation) * Receive oral opioid medications during inpatient postpartum admission * 18 years or older

Exclusion criteria

* Contraindication to NSAID use * Required use of general anesthesia without concurrent neuraxial analgesia * Undergo hysterectomy, or unanticipated surgical procedures during the postpartum period * Are admitted to the intensive care unit during their admission.

Design outcomes

Primary

MeasureTime frameDescription
Postpartum outpatient opioid use8 weeksSelf reported number of opioid tablets used at time of postpartum survey administered 2-4 weeks postpartum

Secondary

MeasureTime frameDescription
Satisfaction with outpatient pain control8 weeks from time of hospital dischargeSatisfaction with pain control at the time of postpartum survey administered 2-4 weeks postpartum
Proper disposal/storage of remaining opioid tablets8 weeks from time of dischargeProportion of patients who report proper disposal/storage of remaining opioid tablets at the time of postpartum survey administered 2-4 weeks postpartum
High opioid use8 weeks from time of hospital dischargeComparison of characteristics of women with \>50% remaining versus \<50% remaining of prescribed opioid tablets

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026